Celsee, Inc., is breaking through the traditional barriers of single-cell analysis and delivering clinical-grade technology designed to support the life sciences revolution and precision medicine.
With rapidly improving analysis tools, scientists now recognize the limitations of studying bulk samples when individual cells are highly heterogeneous. At Celsee, we believe that in the coming years more and more areas of life sciences will focus on single cells.
Celsee’s first product, the Genesis system, enables scientists to analyze and interpret cellular behavior and collect previously inaccessible information for improved results in applications such as proteogenomics, next-generation sequencing, immune monitoring, and cell therapy.
Whether studying one cell or 1 million cells, Celsee’s platform provides a practical, scalable, and efficient approach to accurately analyze previously undetectable or rare cells — all without the pitfalls common to other cell analysis technologies, such as causing damage or missing important cells.